LU91458I2 - "Virus atténué des oreillons,souche RIT4385 (JL-1); virus atténué de la rougeole ; virus atténué de la rubéole ; et virus atténué de la varicelle." - Google Patents

"Virus atténué des oreillons,souche RIT4385 (JL-1); virus atténué de la rougeole ; virus atténué de la rubéole ; et virus atténué de la varicelle."

Info

Publication number: LU91458I2
Authority: LU; Luxembourg
Prior art keywords: virus; attenuated; mumps; strain; rit4385
Prior art date: 1993-11-19

Application number

LU91458C

Other languages

English (en)

Original Assignee

Glaxosmithkline Biolog Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-11-19

Filing date

2008-06-24

Publication date

2008-08-25

1993-11-19 Priority claimed from GB939323820A external-priority patent/GB9323820D0/en

1994-03-31 Priority claimed from GB9406480A external-priority patent/GB9406480D0/en

2008-06-24 Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa

2008-08-25 Publication of LU91458I2 publication Critical patent/LU91458I2/fr

Links

241000711386 Mumps virus Species 0.000 title abstract 2
230000002238 attenuated effect Effects 0.000 title 3
241000712079 Measles morbillivirus Species 0.000 title 1
241000710799 Rubella virus Species 0.000 title 1
241000700605 Viruses Species 0.000 title 1
229960005486 vaccine Drugs 0.000 abstract 2
229940095293 mumps vaccine Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0015—Combination vaccines based on measles-mumps-rubella
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/165—Mumps or measles virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
- C12N2760/18721—Viruses as such, e.g. new isolates, mutants or their genomic sequences
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
- C12N2760/18722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
- C12N2760/18734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
- C12N2760/18761—Methods of inactivation or attenuation
- C12N2760/18762—Methods of inactivation or attenuation by genetic engineering
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36211—Rubivirus, e.g. rubella virus
- C12N2770/36234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Microbiology (AREA)
Immunology (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Communicable Diseases (AREA)
Mycology (AREA)
Epidemiology (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
Oncology (AREA)
Biotechnology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Pulmonology (AREA)
Biomedical Technology (AREA)
General Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Biophysics (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

LU91458C 1993-11-19 2008-06-24 "Virus atténué des oreillons,souche RIT4385 (JL-1); virus atténué de la rougeole ; virus atténué de la rubéole ; et virus atténué de la varicelle." LU91458I2 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB939323820A GB9323820D0 (en)	1993-11-19	1993-11-19	Vaccine
GB9406480A GB9406480D0 (en)	1994-03-31	1994-03-31	Vaccine
PCT/EP1994/003801 WO1995014083A1 (fr)	1993-11-19	1994-11-15	Vaccin contre les oreillons contenant une souche virale jeryl-lynn

Publications (1)

Publication Number	Publication Date
LU91458I2 true LU91458I2 (fr)	2008-08-25

Family

ID=26303889

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LU91458C LU91458I2 (fr)	1993-11-19	2008-06-24	"Virus atténué des oreillons,souche RIT4385 (JL-1); virus atténué de la rougeole ; virus atténué de la rubéole ; et virus atténué de la varicelle."

Country Status (19)

Country	Link
US (4)	US6024962A (fr)
EP (2)	EP1484391A1 (fr)
JP (1)	JPH09504954A (fr)
KR (1)	KR100362051B1 (fr)
CN (2)	CN1150819A (fr)
AT (1)	ATE266090T1 (fr)
AU (1)	AU687922B2 (fr)
CA (1)	CA2176929C (fr)
CY (2)	CY2540B1 (fr)
DE (3)	DE122007000003I2 (fr)
DK (1)	DK0729509T3 (fr)
ES (1)	ES2219658T3 (fr)
LU (1)	LU91458I2 (fr)
NL (1)	NL300336I2 (fr)
NZ (1)	NZ276102A (fr)
PT (1)	PT729509E (fr)
SG (1)	SG52780A1 (fr)
SI (1)	SI0729509T1 (fr)
WO (1)	WO1995014083A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2176929C (fr)	1993-11-19	2002-04-30	Nigel Maurice Harford	Vaccin contre les oreillons contenant une souche virale jeryl-lynn
IL147857A0 (en) *	1999-08-02	2002-08-14	American Cyanamid Co	RESCUE OF MUMPS VIRUS FROM cDNA
PT3274447T (pt) *	2015-03-27	2020-01-21	Cadila Healthcare Ltd	Vacina baseada no vírus da papeira recombinante jeryl lynn 2
US20220023413A1 (en) *	2018-12-12	2022-01-27	The U.S.A., As Represented By The Secretary, Department Of Health And Human Services	Recombinant mumps virus vaccine expressing genotype g fusion and hemagglutinin-neuraminidase proteins
RU2750818C1 (ru) *	2020-11-19	2021-07-05	Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова" (ФГБНУ НИИВС им. И.И. Мечникова	Вирусный штамм для получения аттенуированной живой культуральной вакцины для профилактики и лечения опоясывающего герпеса для взрослого населения
CN114457046A (zh) *	2022-02-16	2022-05-10	科兴（大连）疫苗技术有限公司	一种稀释法传代纯化腮腺炎病毒的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3555149A (en)	1968-07-05	1971-01-12	Merck & Co Inc	Mumps vaccine and its preparation
US4337242A (en)	1980-02-05	1982-06-29	Merck & Co., Inc.	Vaccine stabilizer containing L-glutamic acid and L-arginine
JP3026029B2 (ja) *	1991-04-26	2000-03-27	財団法人阪大微生物病研究会	組換え水痘ウイルスとその作製法
CA2176929C (fr)	1993-11-19	2002-04-30	Nigel Maurice Harford	Vaccin contre les oreillons contenant une souche virale jeryl-lynn

1994
- 1994-11-15 CA CA002176929A patent/CA2176929C/fr not_active Expired - Lifetime
- 1994-11-15 EP EP04075732A patent/EP1484391A1/fr not_active Withdrawn
- 1994-11-15 JP JP7514221A patent/JPH09504954A/ja active Pending
- 1994-11-15 KR KR1019960702618A patent/KR100362051B1/ko not_active Expired - Lifetime
- 1994-11-15 EP EP95900751A patent/EP0729509B1/fr not_active Expired - Lifetime
- 1994-11-15 PT PT95900751T patent/PT729509E/pt unknown
- 1994-11-15 ES ES95900751T patent/ES2219658T3/es not_active Expired - Lifetime
- 1994-11-15 DK DK95900751T patent/DK0729509T3/da active
- 1994-11-15 NZ NZ276102A patent/NZ276102A/en not_active IP Right Cessation
- 1994-11-15 DE DE122007000003C patent/DE122007000003I2/de active Active
- 1994-11-15 US US08/649,654 patent/US6024962A/en not_active Expired - Lifetime
- 1994-11-15 CN CN94194807A patent/CN1150819A/zh active Pending
- 1994-11-15 SG SG1996009415A patent/SG52780A1/en unknown
- 1994-11-15 AU AU81441/94A patent/AU687922B2/en not_active Expired
- 1994-11-15 DE DE69433760T patent/DE69433760T2/de not_active Expired - Lifetime
- 1994-11-15 CN CN2010101643698A patent/CN101948816A/zh active Pending
- 1994-11-15 DE DE1994633760 patent/DE122007000003I1/de active Pending
- 1994-11-15 WO PCT/EP1994/003801 patent/WO1995014083A1/fr not_active Ceased
- 1994-11-15 AT AT95900751T patent/ATE266090T1/de active
- 1994-11-15 SI SI9430462T patent/SI0729509T1/xx unknown
2000
- 2000-12-22 US US09/748,343 patent/US20020018784A1/en not_active Abandoned
2002
- 2002-08-07 US US10/213,965 patent/US6656476B2/en not_active Expired - Fee Related
2003
- 2003-11-03 US US10/699,751 patent/US6899884B2/en not_active Expired - Fee Related
2005
- 2005-09-30 CY CY0500054A patent/CY2540B1/xx unknown
2008
- 2008-02-12 NL NL300336C patent/NL300336I2/nl unknown
- 2008-02-19 CY CY2008005C patent/CY2008005I2/el unknown
- 2008-06-24 LU LU91458C patent/LU91458I2/fr unknown

Also Published As

Publication number	Publication date
US20020018784A1 (en)	2002-02-14
EP0729509B1 (fr)	2004-05-06
US6899884B2 (en)	2005-05-31
ATE266090T1 (de)	2004-05-15
AU8144194A (en)	1995-06-06
DE69433760T2 (de)	2005-05-12
HK1012421A1 (en)	1999-07-30
JPH09504954A (ja)	1997-05-20
US6024962A (en)	2000-02-15
ES2219658T3 (es)	2004-12-01
SG52780A1 (en)	1998-09-28
PT729509E (pt)	2004-09-30
CN101948816A (zh)	2011-01-19
EP0729509A1 (fr)	1996-09-04
DK0729509T3 (da)	2004-08-16
SI0729509T1 (en)	2004-08-31
US20030095984A1 (en)	2003-05-22
NZ276102A (en)	1998-04-27
KR960705919A (ko)	1996-11-08
WO1995014083A1 (fr)	1995-05-26
US6656476B2 (en)	2003-12-02
US20040120969A1 (en)	2004-06-24
KR100362051B1 (ko)	2003-04-11
CN1150819A (zh)	1997-05-28
DE122007000003I1 (de)	2007-05-24
CY2008005I2 (el)	2018-01-10
DE122007000003I2 (de)	2011-01-13
EP1484391A1 (fr)	2004-12-08
DE69433760D1 (de)	2004-06-09
NL300336I1 (nl)	2008-04-01
AU687922B2 (en)	1998-03-05
CA2176929A1 (fr)	1995-05-26
CY2008005I1 (el)	2012-01-25
NL300336I2 (nl)	2009-01-05
CA2176929C (fr)	2002-04-30
CY2540B1 (en)	2006-06-28

Publication	Publication Date	Title
AU1471797A (en)	1997-06-12	Hybrid protein between CS from plasmodium and HBsAG
LU91592I2 (fr)	2009-10-12	Combinaison d'anatoxine diphtérique, d'anatoxine tétanique, d'anatoxine coquelucheuse, d'hémagglutinine filamenteuse, de pertactine, d'antigène de surface recombinant du virus de l'hépatite B (protéine S) et de virus poliomyélitique inactivé type 1, type2 et type 3 (Infanrix Penta)
LU91458I2 (fr)	2008-08-25	"Virus atténué des oreillons,souche RIT4385 (JL-1); virus atténué de la rougeole ; virus atténué de la rubéole ; et virus atténué de la varicelle."
ATE295895T1 (de)	2005-06-15	Genetischer impfstoff gegen den immunschwäche virus
DE69535249D1 (de)	2006-11-09	Rekombinantes Papillomavirus L1 Protein
ZA904915B (en)	1991-06-26	Varicella-zoster virus glycoproteins gpi,gpii and gpiii and their use in vaccines
AU580059B2 (en)	1988-12-22	Vaccine against rabies and preparation process thereof
DK0744027T3 (da)	2005-06-13	Anvendelse af fremgangsmåder til identifikation af hydrofile signaloligopeptider
FR2693655B1 (fr)	1994-10-14	Vaccin antirabique avirulent.
ATE530563T1 (de)	2011-11-15	Rekombinante proteine einer pakistanischen hepatitis e variante und ihre verwendung in diagnoseverfahren und impfungen
GR3026302T3 (en)	1998-06-30	Virus strain against pig pseudorabies and vaccines containing the said virus.
DE69814884D1 (de)	2003-06-26	Hepatitis b virale polypeptide
EP0563288A4 (en)	1994-08-24	Immunopotentiation of vaccines, particularly swine pleuropneumonia vaccines